Can-Fite BioPharma Ltd. (CANF)

4.55 -0.20 (-4.21%) USD  |  NYAM  |  Mar 02, 10:51
More

Can-Fite BioPharma EV to Revenues

EV to Revenues Chart

View EV to Revenues for CANF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Compugen Ltd. Upgrade
Pluri, Inc. Upgrade
BioLineRx Ltd. Upgrade
XTL Biopharmaceuticals Ltd. --
Evogene Ltd. Upgrade